Literature DB >> 23832486

Diabetes impairs synaptic plasticity in the superior cervical ganglion: possible role for BDNF and oxidative stress.

K H Alzoubi1, O F Khabour, I A Alhaidar, A M Aleisa, K A Alkadhi.   

Abstract

The majority of diabetics develop serious disorders of the autonomic nervous system; however, there is no clear understanding on the causes of these complications. In this study, we examined the effect of streptozocin (STZ)-induced diabetes on activity-dependent synaptic plasticity, associated levels of brain-derived neurotrophic factor (BDNF) and antioxidant biomarkers in the rat sympathetic superior cervical ganglion. Diabetes (STZ-induced) was achieved by a single intraperitoneal injection of streptozocin (55 mg/kg).Compound action potentials were recorded from isolated ganglia before (basal) and after repetitive stimulation, or trains of paired pulses to express ganglionic long-term potentiation (gLTP) or long-term depression (gLTD). The input/output curves of ganglia from STZ-treated animals showed a marked rightward shift along most stimulus intensities, compared to those of ganglia from control animals, indicating impaired basal synaptic transmission in ganglia from STZ-induced diabetic animals. Repetitive stimulation induced robust gLTP and gLTD in ganglia isolated from control animals; the same protocols failed to induce gLTP or gLTD in ganglia from STZ-induced diabetic animals, indicating impairment of activity-dependent synaptic plasticity in these animals. Molecular analysis revealed significant reduction in the levels of BDNF and the ratio of glutathione/oxidized glutathione. Additionally, the activity of glutathione peroxidase, glutathione reductase, catalase, and the levels of thiobarbituric acid-reactive substances were increased in ganglia from STZ-treated animals. In conclusion, impaired basal synaptic transmission and synaptic plasticity are associated with reduced BDNF and altered oxidative stress biomarkers in the sympathetic ganglia from STZ-induced diabetic animals, suggesting a possible correlation of these factors with the manifestations of STZ-induced diabetes in the peripheral nervous system.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23832486     DOI: 10.1007/s12031-013-0061-1

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  54 in total

Review 1.  Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?

Authors:  Kawser Akter; Emily A Lanza; Stephen A Martin; Natalie Myronyuk; Melanie Rua; Robert B Raffa
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

2.  Effect of melatonin and vitamin E on diabetes-induced learning and memory impairment in rats.

Authors:  Mehmet Tuzcu; Giyasettin Baydas
Journal:  Eur J Pharmacol       Date:  2006-03-20       Impact factor: 4.432

Review 3.  Metabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseases.

Authors:  S M De La Monte
Journal:  Panminerva Med       Date:  2012-09       Impact factor: 5.197

4.  Inhibition of ganglionic long-term potentiation decreases blood pressure in spontaneously hypertensive rats.

Authors:  K A Alkadhi; S A Otoom; F L Tanner; D Sockwell; Y H Hogan
Journal:  Exp Biol Med (Maywood)       Date:  2001-12

5.  Neurons undergo apoptosis in animal and cell culture models of diabetes.

Authors:  J W Russell; K A Sullivan; A J Windebank; D N Herrmann; E L Feldman
Journal:  Neurobiol Dis       Date:  1999-10       Impact factor: 5.996

6.  Induction and maintenance of ganglionic long-term potentiation require activation of 5-hydroxytryptamine (5-HT3) receptors.

Authors:  K A Alkadhi; D Salgado-Commissariat; Y H Hogan; S B Akpaudo
Journal:  J Physiol       Date:  1996-10-15       Impact factor: 5.182

7.  Distribution and localization of pro-brain-derived neurotrophic factor-like immunoreactivity in the peripheral and central nervous system of the adult rat.

Authors:  Xin-Fu Zhou; Xing-Yun Song; Jin-Hua Zhong; Shahram Barati; Fiona H-H Zhou; Stephen M Johnson
Journal:  J Neurochem       Date:  2004-11       Impact factor: 5.372

8.  Neurotransmission through sympathetic ganglia of spontaneously hypertensive rats.

Authors:  J C Magee; G G Schofield
Journal:  Hypertension       Date:  1992-09       Impact factor: 10.190

9.  Retrograde axonal transport of intravenously administered 125I-nerve growth factor in rats with streptozotocin-induced diabetes.

Authors:  R E Schmidt; C W Modert; H K Yip; E M Johnson
Journal:  Diabetes       Date:  1983-07       Impact factor: 9.461

10.  Evaluation of oxidative stress markers in pathogenesis of diabetic neuropathy.

Authors:  Jacek Kasznicki; Marcin Kosmalski; Agnieszka Sliwinska; Malgorzata Mrowicka; Malgorzata Stanczyk; Ireneusz Majsterek; Jozef Drzewoski
Journal:  Mol Biol Rep       Date:  2012-06-21       Impact factor: 2.316

View more
  2 in total

1.  Acute and long-term effects of intracerebroventricular administration of α-ketoisocaproic acid on oxidative stress parameters and cognitive and noncognitive behaviors.

Authors:  Luciane Taschetto; Giselli Scaini; Hugo G Zapelini; Ândrea C Ramos; Giulia Strapazzon; Vanessa M Andrade; Gislaine Z Réus; Monique Michels; Felipe Dal-Pizzol; João Quevedo; Patrícia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2017-05-27       Impact factor: 3.584

2.  Geniposide alleviates depression-like behavior via enhancing BDNF expression in hippocampus of streptozotocin-evoked mice.

Authors:  Junming Wang; Peili Duan; Ying Cui; Qing Li; Yanran Shi
Journal:  Metab Brain Dis       Date:  2016-06-16       Impact factor: 3.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.